Alendronate-Anionic Clay Nanohybrid for Enhanced Osteogenic Proliferation and Differentiation

BACKGROUND: Alendronate (AL), a drug for inhibiting osteoclast-mediated bone-resorption, was intercalated into an inorganic drug delivery nanovehicle, layered double hydroxide (LDH), to form a new nanohybrid, AL-LDH, with 1:1 heterostructure along the crystallographic C-axis. Based on the intercalat...

Descripción completa

Detalles Bibliográficos
Autores principales: Piao, Huiyan, Kim, Myung Hun, Cui, Meiling, Choi, Goeun, Choy, Jin-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356027/
https://www.ncbi.nlm.nih.gov/pubmed/30718990
http://dx.doi.org/10.3346/jkms.2019.34.e37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356027/
https://www.ncbi.nlm.nih.gov/pubmed/30718990
http://dx.doi.org/10.3346/jkms.2019.34.e37

Ejemplares similares